Skip to content

Ketamine assisted psychotherapy in postpartum mood and anxiety disorders: a limited case series

Alka Christnacht, Therry Rose J Eparwa, Emily Whinkin, Sunil K Aggarwal

Frontiers in Psychiatry January 22, 2026 DOI: 10.3389/fpsyt.2025.1661604 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Retrospective case series Case report Peer reviewed
Sample size 3
Population Postpartum individuals with PMADs who received KAP within the first two years postpartum
Intervention Ketamine assisted psychotherapy
Duration First two years postpartum
Topics Anxiety Ketamine Esketamine Psychedelic-assisted therapy
Keywords Distress Postpartum depression Postpartum period Modalities Psychotherapist Mood disorders Clinical psychology Childbirth Treatment modality Pregnancy
Key findings Ketamine assisted psychotherapy may provide utility in treating postpartum mood and anxiety disorders by facilitating psychedelic insights that address symptoms.

Abstract

The postpartum period is notorious for rapid and profound changes for birthing individuals and their families. Significant shifts to hormonal and physical health, routines and family roles, and the salience of personal and community risk factors all contribute to potential psychiatric and psychological distress for parents, sometimes diagnosed as a postpartum mood or anxiety disorder (PMAD). Existing pharmacologic treatment modalities for PMADs do not comprehensively address the profound shifts of the postpartum period, often inadequate at reaching peak therapeutic efficacy in a shorter time frame, in patient accessibility, or offering sustained benefit. Ketamine assisted psychotherapy (KAP), is increasingly recognized as a therapeutic option for a range of psychiatric disorders and has been explored as a modality to prevent PMADs when used during Cesarean births. This retrospective case series examines three cases where ketamine assisted psychotherapy (KAP) was introduced during the first two years postpartum as part of a comprehensive treatment plan for PMADs. This study describes the utility of ketamine assisted psychotherapy to the postpartum individual, and offers perspective on the impact of psychedelic insights through treatment of PMAD symptoms

Comparable studies

Other case reports and case series on ketamine and psychedelic-assisted therapy, most cited first.

Study Year Design Participants
Ketamine-assisted psychotherapy in adolescents with multiple psychiatric diagnoses. Adolescents aged 14–19 with comorbid psychiatric diagnoses including... 2023 Case series n = 4
Case report: Adult with bipolar disorder and autism treated with ketamine assisted psychotherapy. A 29-year-old man with bipolar disorder, Autism Spectrum Disorder, and type 2 diabetes 2024 Case study n = 1
Reconnecting through dissociation: a 5-month follow-up case study on ketamine-assisted psychotherapy for anorexia nervosa. Female patient in her late twenties with anorexia nervosa and comorbid depression 2025 Case report n = 1
Ketamine-Assisted Psychotherapy for Treatment of Co-occurring Borderline Personality Disorder and Depression: A Case Study. A patient with co-occurring borderline personality disorder and depression 2025 Case study n = 1
Qualitative analysis of a patient's experience of ketamine-assisted psychotherapy for substance use disorder: Empirical synergies with twelve-step programs 28-year-old female treated for alcohol and opioid use disorder 2025 Case study n = 1

Explore topics

By condition and practice